Found on pharmacist.com
Group by:
Title Date Type
National data trends show long-term opioid prescriptions increased over time
Loren Bonner, senior editor
The population-based cross-sectional analysis, published in JAMA Network Open on March 15, looked at opioid prescriptions filled among U.S. residents at community pharmacies between January 1, 2006, and December 31, 2017. Researchers considered various measures across states: The annual amount…
Mar 19, 2019 Article
APhA Corporate Supporter Program
APhA is proud to offer an APhA Corporate Supporter Program that will increase opportunities for dialogue between companies and APhA leadership. Supporters are invited to work strategically with APhA to improve medication use and advance patient care. Being an APhA Corporate Supporter benefits…
Jul 06, 2012 Basic page
New guidelines advise against aspirin to prevent heart disease
Wall Street Journal (03/18/19) Loftus, Peter
The American College of Cardiology (ACC) and American Heart Association on Sunday said low-dose aspirin should not be given on a routine basis for the purpose of preventing heart attacks and other heart disease in people aged 70 years and older or adults of any age who are at increased risk of…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
Major U.S. study finds Apple Watch can detect heart issues
The Hill (03/16/19) Frazin, Rachel
Preliminary results from the Apple Heart Study indicate that the Apple Watch can detect irregular heart rhythms. In the study, reported by researchers with the Stanford University School of Medicine, 0.5% (about 2,000 people) of the more than 400,000 participants wearing Apple Watches in the 8-…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
Surgery no better than medication at preventing serious complications of AF
NIH News Release (03/15/19)
Two new papers in the Journal of the American Medical Association discuss the effects of catheter ablation vs. drug therapy in the treatment of patients with atrial fibrillation. The articles report the outcomes of the Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
Legacy announces voluntary recalls of losartan tablets
FDA Recalls, Market Withdrawals, & Safety Alerts (03/15/19)
Legacy Pharmaceutical Packaging said, in two separate announcements Friday, that it is recalling 43 repackaged lots of losartan tablets to the consumer levels. The nationwide recalls follow the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) in an active pharmaceutical…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
Older Americans are awash in antibiotics
New York Times (03/15/19) Span, Paula
Older adults take too many antibiotics, despite efforts by CDC and other groups to reduce the rates. A recent study in the Journal of the American Geriatrics Society found that physicians wrote enough antibiotic prescriptions each year for every individual aged 65 years and older to receive at…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
AAP: No influenza vaccine preference for 2019-20 season
AAP News (03/19) Jenco, Melissa
For the 2019–20 influenza season, the American Academy of Pediatrics (AAP) says it will no longer indicate a preference for the injection versus the nasal spray form of the vaccine for children. The recommendation comes after AAP evaluated current data on vaccination coverage and…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
A trial of a shorter regimen for rifampin-resistant TB
New England Journal of Medicine (03/13/19) Nunn, Andrew J.; Phillips, Patrick P.J.; Meredith, Sarah K.; et al.
Researchers involved in the STREAM clinical study explored whether a shorter-than-recommended course of treatment for multidrug-resistant tuberculosis (TB) would improve outcomes. They recruited adults with pulmonary TB and evidence of resistance to rifampin, which is managed similarly to multi-…
Mar 17, 2019 Publication Pharmacy Today Daily Edition
FDA approves Pfizer's biosimilar to trastuzumab
Pfizer (03/11/19)
FDA has approved trastuzumab-qyyp (Trazimera—Pfizer), a biosimilar to trastuzumab (Herceptin—Genentech), for the treatment of human epidermal growth factor receptor-2 (HER-2) overexpressing breast cancer and HER2 overexpressing metastatic gastric or gastroesophageal junction…
Mar 17, 2019 Publication Pharmacy Today Daily Edition